Tax cut won’t mitigate high prices for cancer, rare diseases medicines, say patient advocacy groups

Drugs that are listed for custom duty waiver are generally those that are not in local production, are under a patent monopoly and block generic competition, they say

Feb 7, 2025 - 20:35
 0  21
Tax cut won’t mitigate high prices for cancer, rare diseases medicines, say patient advocacy groups
Drugs that are listed for custom duty waiver are generally those that are not in local production, are under a patent monopoly and block generic competition, they say

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow